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Abstract
Objective: Multiple sclerosis (MS) is less prevalent in African Americans (AAs) than Caucasians 
(CAs) but in the former the disease course tends to be more severe. In order to clarify the MRI 
correlates of disease severity in AAs, we performed a multimodal brain MRI study to 
comprehensively assess the extent of grey matter (GM) damage and the degree of functional 
adaptation to structural damage in AAs with MS.
Corresponding author: Matilde Inglese, MD, PhD, Department of Neurology, Radiology and Neuroscience, Icahn School of 
Medicine at Mount Sinai, New York, NY. matilde.inglese@mssm.edu, Telephone: 212-824-9310; Fax: 212-348-1310.
Author Contributions
M.I. had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data 
analysis. Study concept and design: MI. Acquisition, analysis, or interpretation of data: all authors. Drafting of the manuscript: MP, 
SC, MH, MI. Critical revision of the manuscript for important intellectual content: all authors. Statistical analysis: MP, SC, MH, MI. 
Obtained funding: MI. Study supervision: MI.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Potential conflicts of interest
Nothing to report.
HHS Public Access
Author manuscript
Mult Scler Relat Disord. Author manuscript; available in PMC 2019 October 01.
Published in final edited form as:
Mult Scler Relat Disord. 2018 October ; 25: 29–36. doi:10.1016/j.msard.2018.06.007.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Methods: In this cross-sectional study, we characterized GM damage in terms of focal lesions 
and volume loss and functional adaptation during the execution of a simple motor task on a sample 
of 20 AAs and 20 CAs with MS and 20 healthy controls (CTRLs).
Results: In AAs, we observed a wider range of EDSS scores than CAs, with multisystem 
involvement being more likely in AAs (p<0.01). While no significant differences were detected in 
lesion loads and global brain volumes, AAs showed regional atrophy in the posterior lobules of 
cerebellum, temporo-occipital and frontal regions in comparison with CAs (p<0.01), with 
cerebellar atrophy being the best metric in differentiating AAs from CAs (p=0.007, AUC=0.96 and 
p=0.005, AUC=0.96, respectively for right and left cerebellar clusters). In AAs, the functional 
analysis of cortical activations showed an increase in task-related activation of areas involved in 
high level processing and a decreased activation in the medial prefrontal cortex compared to CAs.
Interpretation: In our study, the direct comparison of AAs and CAs points to cerebellar atrophy 
as the main differences between subgroups.
Keywords
Grey matter; African Americans; Multiple Sclerosis
Introduction
Multiple sclerosis (MS) is less prevalent in African Americans (AAs) than in Caucasians 
(CAs) (case/control ratio 0.45 vs 1.04, respectively)1 but the disease course tends to be more 
severe in the former, likely due to the concurrence of both genetic susceptibility and 
exposure to environmental risk factors2–4. Although socioeconomics may play a role in 
clinical outcomes, the disability difference between AAs and CAs also exists when the 
comparison is controlled for education, income, and insurance status5. Clinically, AAs not 
only present a lower age at onset6, a preponderance of optico-spinal MS and an increased 
occurrence of multifocal signs and symptoms4, but also a greater risk for secondary 
progression7 and poorer responses to disease-modifying therapies8. Retrospective MRI 
studies have suggested that the more severe course is associated with the higher white matter 
(WM) lesion load and diffuse microstructural damage in normal appearing WM, rather than 
greater whole brain and/or grey matter (GM) atrophy9–11. However, while all previous 
studies have been consistent in reporting a higher number of WM lesions in AAs compared 
to CAs, GM lesions have never been investigated and the findings related to GM atrophy are 
controversial ranging from no difference to significant decrease in GM global volume and 
global cortical thickness in AAs and compared to their CAs counterparts 10–12. To date, a 
comprehensive analysis of GM involvement in AAs is still lacking, despite the key role of 
GM focal and diffuse damage in contributing to clinical disability and in driving the extent 
and pace of MS progression13–19. Therefore, here we present the results of a multimodal 
brain MRI study to comprehensively assess the presence and extent of global and regional 
GM damage in AAs with MS. We hypothesized that greater focal and diffuse damage of 
clinically relevant cortical and subcortical GM regions may account for the difference in 
disease severity between AAs and CAs. Additionally, since greater disability in AAs may be 
the consequence of poor tissue repair capability and/or exhaustion of adaptive compensatory 
mechanisms, we investigated the functional correlates of a simple motor task in AAs versus 
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CAs in order to explore possible differences in functional adaptation between the two racial 
subgroups.
Methods
Study population
Forty patients, with a diagnosis of clinically definite MS according to the International Panel 
diagnostic criteria20 and a relapsing-remitting (RR) course21 were prospectively enrolled. 
Patients underwent clinical evaluation including the Expanded Disability Status Scale 
(EDSS)22 and the 9-Hole Peg Test (9-HPT)23. The presence of multisystem involvement, 
defined as moderate disability in multiple functional systems (EDSS ≥ 4), was evaluated for 
each patient. To be included in the study, patients had to be of AA or CA ancestry, right 
handed, and relapse- and corticosteroid treatment-free for at least 3 months preceding the 
MRI examination. Ethnicity was self-identified by the patient at the time of clinic 
registration. Exclusion criteria consisted of pre-existing medical conditions of depression, 
drug or alcohol abuse and brain pathology other than MS. Twenty age- and gender-matched 
right-handed healthy volunteers of CA ancestry served as healthy controls (CTRLs). 
Approval for the study was obtained from the Institutional Review Board of the Mount Sinai 
School of Medicine, and all participants provided informed written consent.
Image acquisition
All subjects underwent a brain MRI on a 3T scanner (Philips Achieva, The Netherlands) 
with an 8-channel SENSE phased-array head coil. MRI acquisition included: (a) dual echo 
(DE) turbo spin echo (TSE) sequence (TR/TE1/TE2: 2500/10/80 ms; 50 contiguous axial 
slices; voxel size: 1×1×3 mm3); (b) 3D T1 fast field echo (FFE) sequence (TR/TE/TI: 
7.5/3.4/900 ms; 162 sagittal slices; voxel size: 1×1×1 mm3); (c) DIR sequence (TR/TE/TI: 
1100/25/3400 ms; 50 contiguous axial slices; voxel size 1×1×3 mm3).
Finally, in a subsample of 34 subjects (10 CTRLs, 12 AAs, 12 CAs), the following EPI 
sequence was utilized for the fMRI analysis: TR/TE: 3000/30 ms; number of volumes: 80; 
36 contiguous axial slices; voxel size: 2.6×2.6×3.7 mm3.
fMRI Task design
The fMRI experiment used a block design (ABAB), where four epochs of activation were 
alternated with four epochs of rest (30 sec/epoch). All subjects were instructed to perform a 
simple motor task consisting of repetitive, calibrated and conjugated flexion-extension of the 
last four fingers of the right hand. In order to guide movement amplitude, a hard ball was 
placed in the palm of the hand and held in place with the subject’s thumb and adhesive tape. 
Patients and controls were trained before performing the experiments and monitored visually 
during scanning to ensure accurate task performance.
Image Analysis
Lesion count and volumes—T2-hyperintense, T1-hypointense lesion volume (LV), and 
cortical lesion (CL) volume were measured on the DE T2-weighted, T1-weighted and DIR 
images, respectively, using a semi-automated segmentation technique based on user-
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supervised local thresholding (Jim version 5; Xinapse Systems, Northants, England) (http://
www.xinapse.com). All lesions were identified in consensus by two experienced observers 
(MI with more than 10 years and SC with 5 years of experience in brain imaging). In order 
to further improve accuracy of CLs identification, these lesions were identified according to 
published guidelines24. T1-hypointense lesions were identified as areas of focal 
hypointensity compared to the surrounding normal-appearing white matter, visible on the 
T1-weighted sequence and corresponding to a region of high signal intensity on the T2-
weighted images.
WM and GM lesion probability maps—For each patient subgroup (AAs and CAs), 
WM and GM lesion probability maps (LPMs) were obtained using the FMRIB Software 
Library - FSL v5 (www.fmrib.ox.ac.uk/fsl/), as previously described25. In the resulting 
LPM, the intensity of each voxel represents the probability of that voxel to be a lesion in that 
patients’ subgroup.
Global and regional brain volume measures—All volumetric analyses were 
conducted on high-resolution 3D FFE T1-weighed images after correcting for the impact of 
WM lesions (lesions in-painting, LI)26. Calculation of global brain volumes was computed 
in FSL’s SIENAX, obtaining, for each subject, normalized brain volume (NBV), GM 
volume (GMV) and WM volume (WMV)27. Voxel-based morphometry (VBM) analysis was 
performed via SPM 12. The segmented GM images were normalized using the 
Diffeomorphic Anatomical Registration Through Exponentiated Lie Algebra (DARTEL) 
algorithm28. The normalized segmented GM maps (2×2×2 mm3 voxel size) provided by 
DARTEL were then modulated by the Jacobian determinants (derived from the spatial 
normalization procedure) in order to preserve the local GM volumes. Images were smoothed 
using a 8mm FWHM isotropic Gaussian kernel.
fMRI Data Analysis—Preprocessing of functional data was conducted as described in 
Saiote, et al.29. Briefly, to model the on-off periods of the right hand motor task activity, one 
explanatory variable (EV) was defined and convolved with the hemodynamic response 
function (HRF) while the 24 motion parameters calculated during motion correction were 
added as confound EVs. Mean CSF and WM signals were added to the general linear model 
(GLM) as covariates of no interest. Boundary-based registration (BBR)30 was used to 
register each individuals’ functional data to their corresponding T1-weighted brain images 
followed by a linear affine 12 degrees of freedom registration of each individuals’ T1-
weighted brain image to standard MNI space (MNI152 brain template, voxel size: 2mm)31.
Statistical Analysis
Between groups comparisons in terms of clinical and MRI variables, as well as correlation 
and classification accuracy analyses, were carried out using Statistical Package for Social 
Science (SPSS Inc, v. 19.0, Chicago, Ill).
Demographic, clinical and volumetric statistical analyses—A Chi-square test was 
used to compare groups in terms of gender and treatment type. Nonparametric Mann-
Whitney and Kruskal-Wallis tests were used for between-group comparisons of 
Petracca et al. Page 4
Mult Scler Relat Disord. Author manuscript; available in PMC 2019 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
demographic (age) and clinical (EDSS, disease duration, treatment exposure) parameters, as 
appropriate. A binary logistic regression was used to compare AAs and CAs with respect to 
the presence of multisystem involvement. For this analysis, the presence of multisystem 
involvement was the dependent variable and the logistic model included patient subgroups 
(AAs or CAs) with age, gender and disease duration as covariates. Analysis of variance 
(ANOVA) was used for between-group comparison of MRI measures (T2LV, T1LV, CLs 
count and volume, NBV, GMV, WMV) correcting for age and gender.
Voxelwise statistical analyses—The probability of lesion occurrence in AAs and CAs 
was compared with a voxel-wise nonparametric statistic as implemented in FSL’s 
randomise, entering age, gender and T2LV as covariates of no interest (5000 permutations; 
p<0.05, Threshold-Free Cluster Enhancement-TCFE corrected for multiple comparisons).
For the VBM analysis, the normalized modulated GM maps were compared via GLM based 
on Gaussian random field theory32. The design matrix included age, gender and ICV as 
nuisance variables. Results were considered significant for p<0.01, FWE-corrected at cluster 
level (0.05/3, as three different contrasts were probed). Where significant differences 
emerged, signal intensity values were extracted for correlation purposes.
Finally, fMRI group level analyses were completed using the mixed effects model FSL 
FLAME. One sample t-tests were used to model group mean activation and two-sample t-
tests were used to model comparison between subgroups. The results were converted to Z-
values and then thresholded at Z=2.3, with significance level set at p<0.05 and FWE 
corrected for multiple comparisons at cluster level.
Anatomical labeling of GM regions was derived from the Talairach atlas33.
Correlation analyses and classification accuracy—Correlations between MRI 
metrics that differed between AAs and CAs and clinical disability were probed using a 
partial correlation analysis, with age, gender and disease duration as covariates of no 
interest. Logistic regression models were computed to assess the utility of each MR measure 
for the differentiation of CAs from AAs after adjusting for age, gender and disease duration. 
Mean classification accuracy was calculated to show the predictive power of the MR 
measures during the classification process by measuring area under the curve (AUC) of the 
free-response receiver operating characteristic (ROC) analysis.
All reported p values are two-sided with statistical significance defined as p<0.05. Given the 
exploratory nature of the study, no correction for multiple comparisons was performed, with 
the exception of the voxelwise statistical analyses. Therefore, results have to be considered 
as descriptive.
Results
Demographic and clinical characteristics of the study population are shown in Table 1. The 
comparison of the three groups (CTRLs, AAs, CAs) in terms of demographics showed a 
trend of difference for gender (p=0.048) but not for age (p=0.841). AAs and CAs were not 
significantly different in terms of age, gender, age at disease onset, disease duration, EDSS, 
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treatment type or treatment exposure at the time of MRI (p>0.05 for all). In both subgroups, 
90% of the subjects were on disease-modifying therapies, with the following distribution: 
61% of AAs and CAs on interferon β-1a treatment (33% on Avonex®, 28% on Rebif® in 
both subgroups), 11% of AAs and 17% of CAs on glatiramer acetate, 11% of AAs and 22% 
of CAs on natalizumab and 17% of AAs on rituximab. Although not significantly different, 
AAs presented a wider range of EDSS scores, a higher percentage of subjects with moderate 
involvement of multiple functional systems (30% of AAs with EDSS ≥ 4 vs 0% of CAs with 
EDSS ≥ 4) and a higher 9-HPT score mean value compared to CAs (Table 1). Multisystem 
involvement was significantly predicted by race, considering age, gender and disease 
duration as covariates (p<0.01).
Lesion count and volumes
There were no WM lesions detected on T2- and T1-weighted images in CTRLs. Although 
AAs had a greater mean T2LV, T1LV, CLs volume and count compared to CAs, the 
difference did not reach the statistical significance (Table 2).
WM and GM LPMs
The distributions of T2 lesions and CLs were similar in AAs and CAs (Figure 1), with no 
significant difference in regional WM and GM lesion frequency between the two subgroups 
of patients. The peak of WM lesion frequency was in the right periventricular WM for both 
racial subgroups, with AAs showing higher probabilities than CAs (52.3% vs 40%). The 
peak of GM lesion frequency was in the left superior frontal gyrus (15.8%) in AAs and in 
the left middle frontal gyrus (16.7%) in CAs.
Global normalized brain volume measures
Compared to CTRLs, AAs and CAs showed no differences in terms of global brain volumes 
(p>0.05). Similarly, no differences in NBV, GMV or WMV were detected when comparing 
the two racial subgroups (p>0.05).
Mean values of normalized brain volumes and results of the between group comparisons are 
reported in Table 2.
Voxel-based GM volume measure
Compared to CTRLs, AAs showed lower GM volumes in the uncus, cerebellum, inferior 
temporal gyrus and paracentral lobule (all with p≤0.001), whereas CAs showed lower GM 
volume in the thalamus (p=0.003) (Figure 2A and B). When the two racial subgroups were 
compared, AAs showed lower GM volumes in the cerebellum, uncus, supplementary motor 
area, and visual associative cortex compared to CAs (lingual gyrus p=0.004, all others 
p<0.001) (Figure 2C). There were no areas of relative GM atrophy detected in CAs 
compared to AAs.
A complete list of the results of the VBM analysis is reported in Table 3.
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Task-Associated fMRI Activations: Between-Group Comparisons
There were no differences in age or gender between the three groups (CTRLs, AAs, CAs) 
included in the fMRI analysis (p=0.870 and p=0.648, respectively), with the two patient 
subgroups (AAs and CAs) also showing no differences in terms of age at onset (p=0.713), 
disease duration (p=0.887), EDSS (p=0.478), and treatment exposure (p=0.514).
Compared to CTRLs, AAs showed an increased activation of the contralateral parietal cortex 
as well as ipsilateral insular cortex (Figure 3A), while CAs showed an increased activation 
of the contralateral premotor cortex and precuneus (Figure 3B). Finally, when comparing 
CAs and AAs, the latter group showed reduced activation of the contralateral medial frontal 
gyrus (Figure 3C). Results of the between group comparisons are listed in Table 4.
Correlations between MRI parameters and clinical measures
In patients, significant correlations were identified between EDSS and clusters of atrophy in 
the right and left cerebellum (r=−0.356, p=0.030 and r=−0.331, p=0.046, respectively), left 
uncus (r=−0.340, p=0.039) and left secondary visual cortex (r=−0.361, p=0.028). Significant 
correlations were also identified between 9-HPT and clusters of atrophy in right and left 
cerebellum (r=−0.415, p=0.011 and r=−0.378, p=0.021, respectively) and left secondary 
visual cortex (r=−0.405, p=0.013).
Classification accuracy analysis
Among the MRI metrics that differed between racial subgroups, different indices of regional 
atrophy were able to differentiate AAs from CAs patients (supplementary motor area 
atrophy p=0.004, AUC=0.93; left uncus atrophy p=0.003, AUC=0.92; right uncus atrophy 
p=0.003, AUC=0.93; visual association cortex atrophy p=0.008, AUC=0.92), with the best 
predictors being the clusters of cerebellar atrophy (p=0.007, AUC=0.96 and p=0.005, 
AUC=0.96, respectively for right and left cerebellar clusters).
Discussion
Our study confirms and expands the current knowledge about GM involvement in MS 
patients of AA ancestry, providing a comprehensive characterization of GM in terms of 
structural damage and functional reorganization.
Structural damage-GM and WM lesion loads
Regarding focal damage, the highest tendency of lesion accrual in MS patients of AA 
ancestry appears not limited, as previously reported, to the WM tissue9,10 but seems also to 
affect the cortex in terms of CLs. Nonetheless, the higher CL prevalence we report in our 
AA population has to be interpreted with caution, considering that the between-group 
difference in terms of CL only shows a significance trend and that the DIR sequence utilized 
for CL identification does not represent the gold standard in terms of sensitivity for CL 
classification34.
Additionally, we identified a higher WM lesion load and higher lesion frequency in WM 
tracts in AAs compared to CAs, but this difference, in contrast with previous reports9–12, did 
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not reach the statistical significance. A possible explanation of this discrepancy could be 
researched in the lower disease duration and mean age at MRI of our population compared 
to those previously analysed9–12. Furthermore, it should be noted that other characteristics of 
our population, such as immunomodulatory therapy, could also have influenced our findings. 
Indeed, although the two racial subgroups did not differ in terms of treatment exposure, a 
higher percentage of AAs were on treatment with anti-inflammatory monoclonal antibodies 
compared to CAs (38% vs 22%).
Structural damage-GM atrophy
After exploring the presence and distribution of focal damage, we evaluated GM in terms of 
atrophy through the estimation of global brain volumes and voxel-wise analysis. No 
differences were identified between MS patients and healthy controls in terms of global 
brain volumes and, although this finding might be surprising, the lack of significance could 
be related to the small sample size and the relative lack of sensitivity of a global measure, as 
mean values for each group show agreement with the literature, with AAs presenting larger 
brain volumes than CAs.9,10
The two racial subgroups (AAs and CAs) showed different clusters of regional GM atrophy 
when compared to healthy controls. Although the lack of an AA control group might limit 
the interpretation of these findings, as the observed difference in volumes could be driven by 
race rather than being MS-specific, the few data available in the literature suggest that race-
specific differences in brain volume would justify the presence of larger, rather than smaller 
global and regional volumes in African-Americans in comparisons with Caucasians 35,36
While no differences in global brain volumes were detected in AAs in comparison with CAs, 
the voxel-wise analysis revealed the presence of significant cerebellar atrophy in AAs 
compared to CAs, mainly involving the posterior lobules. Additional areas of GM loss were 
disclosed in the temporo-occipital and frontal regions. In line with previous findings9,10, 
global brain volumes did not differ between racial subgroups but, increasing the sensitivity 
of the analysis through the exploration of regional volumetry, we found clusters of GM loss 
in motor areas (i.e., supplementary motor area and cerebellum), parahippocampal regions 
and occipital lobe in AAs. The presence of GM volume loss in these specific areas in AAs in 
comparison with CA MS patients could provide the background for the more severe 
impairment in learning and memory function as well as the gait difficulties reported in 
AAs5,9,37. Our results about regional atrophy only partially overlap with the findings of a 
recent study reporting cortical thickness differences between AAs and CAs11. This lack of 
complete concordance could be related to methodological differences in GM atrophy 
estimation, (i.e., the lower sensitivity of the cortical thickness estimation method in detecting 
subtle atrophy, especially in medial cortical areas, limbic and temporal regions, compared to 
voxel-based analysis38). Furthermore, the lack of complete concordance could also be 
related to the population characteristics, as the patients included in our study were younger, 
with shorter disease duration and with lower EDSS scores. Finally, it is possible to speculate 
that the pattern of GM atrophy described here could represent the initial stage of the 
widespread involvement reported in more advanced phases of the disease11.
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Indeed, the concurrent damage of different brain areas could represent the anatomical 
substrate of the multisystemic involvement that is one of the major characteristics of the 
disease course in AAs4. In our population, although AAs and CAs did not differ in terms of 
individual measures of clinical disability (EDSS, 9-HPT), AAs showed a higher frequency 
of multisystem involvement. The direct comparison of the two racial subgroups highlights 
the presence of more severe GM damage in AAs with regional GM atrophy emerging as the 
main differences between AAs and CAs patients. When exploring the ability of different 
MR metrics to differentiate the AA from CA patients, cerebellar atrophy emerged as the best 
predictor. Cerebellar atrophy has recently been reported as a sensitive and clinically 
meaningful outcome measure in progressive MS39,40. Similarly, cerebellar damage could 
represent a crucial factor for disability expression in AAs.
Functional adaptation
Previous studies have demonstrated how structural damage in MS impacts functional activity 
and how hyper-activation of the sensorimotor network might occur as an attempt to maintain 
motor ability41,42. In our MS population, the functional analysis of cortical activations, 
although limited in power by the small size of our sample, showed, as expected, an increase 
in task-related activation in key regions of the sensorimotor network when compared to 
CTRLs. However, while CAs presented an increase in activation in the premotor area and 
associative cortex responsible for visuo-spatial imagery43, AAs showed an increased activity 
in areas involved in higher level processing, such as tactile object recognition and integration 
of somatosensory information44,45. Furthermore, when a direct comparison between the two 
racial subgroups was performed, AAs showed a decreased activation in the medial prefrontal 
cortex compared to CAs, an area known to play a role in the selection and inhibitory control 
of hand movements46. Similar to what has been reported in progressive MS patients41,47, the 
pattern of increased activity observed in AAs suggests that the recruitment of multimodal 
integration regions during the execution of a simple motor task represents a consequence of 
the prominent structural damage observed in this population, while the reduced activation in 
the prefrontal cortex might indicate a decrease in the compensatory ability of AAs compared 
to CAs.
Study limitations
When testing the impact of structural damage on clinical outcomes, we found moderate 
associations between infra-tentorial and temporo-occipital GM damage and clinical 
disability. The lack of stronger correlations, although disappointing, could be partially 
explained by the observation that regions of GM damage accrual were mainly located in 
non-motor areas, while the available clinical scores were reflecting motor capabilities. For 
this reason, the lack of neuropsychological examination, together with the relatively small 
sample size, has to be considered as one of the main limitations of this study. Other 
limitations have to be taken into account, such as the lack of spinal cord damage 
quantification, the lack of data regarding participants’ socioeconomic status and the absence 
of an AA control group. The latter, in particular, might explain the higher, although not 
significant, mean values for global brain volumes observed in AAs in comparison with 
controls. Notwithstanding all the acknowledged limitations, the present study is the first 
attempt to fully characterize the extent and regional distribution of GM damage in AAs. 
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Further studies on a broader population are needed to fully elucidate the possible causes of 
the severe clinical presentation and progression of MS in AAs, but our exploratory findings 
provide the basis for future investigation on the pathological substrates of inter-racial 
difference in MS.
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Figure 1. 
White matter and grey matter lesion probability maps in African American and Caucasian 
MS patients, overlaid on the MNI standard brain template, showing the probability of each 
voxel to contain a lesion in each racial subgroup (p<0.05, TCFE corrected for multiple 
comparisons). Peaks of WM and GM lesion frequency are identified by crosshairs. The 
color scale denotes the probability range. Abbreviations: AAs=African-American; 
CAs=Caucasians; WM=white matter; GM=grey matter; LPM=lesion probability map.
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Figure 2. 
Results of the Voxel Based Morphometry analysis showing significant differences between 
groups. Areas of relative GM reduction in African American MS patients compared to 
controls (A), Caucasian MS patients compared to controls (B) and African American 
compared to Caucasian patients (C) are showed in red, overlaid on the 3D brain surface 
rendering of a single normal subject provided in SPM12 (p<0.01, FWE-corrected at cluster 
level).
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Figure 3. 
Relative activations during the performance of the motor task in African-American patients 
vs. controls (A), Caucasian patients vs. controls (B) and African-American vs. Caucasian 
patients (C). Clusters showing a significant difference in activation are shown overlaid on 
the MNI standard brain template (p<0.05, cluster corrected for multiple comparisons). The 
color scale represents the Z value.
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Table 1.
Demographic and clinical characteristics of the study population.
AAs CAs CTRLs p-value* p-value§
M/F (n) 5/15 6/14 8/12 0.723a 0.048 a
Age at onset [yrs] 28.6 ± 7.3 28.4 ± 6.4 - 0.841b -
Age at MRI [yrs] 34.6 ± 10.4 33.8 ± 6.3 33.4±10.4 0.820b 0.841 c
Disease duration [yrs] 6.0 ± 4.3 5.3 ± 4.4 - 0.620b -
EDSS score (median and range) 1.5 (1.0-6.0) 1.7 (1.0-3.5) - 0.640b -
9-HPT score [sec] 25.0 ± 7.2 21.6 ± 4.5 - 0.157b -
Patient under treatment (n) 18/20 18/20 - 1a -
Treatment exposure [yrs] 3.0 ± 3.3 4.6 ± 4.5 - 0.277b -
Abbreviations: AAs=African Americans; CAs=Caucasians; CTRLs=controls; EDSS= Expanded Disability Status Score; F=female; M=male; 
n=number; yrs=years; 9-HPT=9-hole peg test. Unless otherwise specified, all values are expressed as mean ± standard deviation.
aChi-square test.
b
Mann-Whitney test.
c
Kruskal-Wallis test.
*AAs vs CAs.
§AA vs CAs vs CTRLs.
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Table 2.
Lesion and brain volume measures in patients and CTRLs.
AAs CAs CTRLs pa pb pc
T2 LV (mL) 3.60 ± 3.91 3.03 ± 2.44 - - - 0.508
T1 LV (mL) 0.57 ± 0.43 0.52 ± 0.62 - - - 0.743
CLs (n) 8.79 ± 6.53 6.60 ± 4.68 - - - 0.149
CL-V (mL) 0.33 ± 0.28 0.22 ± 0.18 - - 0.072
NBV (mL) 1511.37 ± 110.49 1485.35 ± 75.52 1499.14 ± 84.00 0.977 0.591 0.357
NWMV (mL) 706.06 ± 56.94 693.14 ± 33.70 703.09 ± 52.67 0.961 0.497 0.399
NGMV (mL) 805.31 ± 56.05 792.21 ± 41.37 796.04 ± 44.06 0.910 0.796 0.354
Abbreviations: AAs=African Americans; CA=Caucasians; CL=cortical lesions; CL-V=cortical lesions volume; LV=lesion volume; 
NBV=normalized brain volume; NWMV=normalized white matter volume; NGMV=normalized grey matter volume.
aANOVA age and gender corrected (AAs vs CTRLs; p<0.05).
bANOVA age and gender corrected (CAs vs CTRLs; p<0.05).
cANOVA age and gender corrected (AAs vs CAs; p<0.05).
All the values are expressed as mean ± SD.
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Table 3.
Regions showing significant grey matter loss in MS patients (p<0.01, FWE-corrected at cluster level).
Comparison Regions Side BA MNI coordinates (x,y,z) T value Cluster size p-value
AAs<CTRLs Uncus L 6 26, −8, −50 6.32 16403 < 0.001
CBL R - 16, −58, −58 5.99 5591 < 0.001
CBL L - −32, −54, −22 5.37 1019 0.001
ITG R 37 48, −54, −4 4.91 1193 < 0.001
PCL R 3 14, −34, 60 4.67 1130 < 0.001
CAs<CTRLs Thalamus R - 8, −8, 12 4.95 730 0.003
AAs<CAs CBL R - 12, −74, −50 6.37 1649 < 0.001
Uncus/FG R 38 24, −8, −46 6.30 1400 < 0.001
Uncus/FG L 38 −24, −10, −48 5.82 1263 < 0.001
SFG L 6 −20, 22, 60 5.74 1065 < 0.001
CBL L - −12, −66, −60 5.68 1397 < 0.001
LG L 18 0, −68, 6 4.95 720 0.004
Abbreviations: AAs=African Americans; BA=Brodmann area; CAs=Caucasians; CBL=cerebellum; CTRLs=controls; FG=fusiform gyrus; 
ITG=inferior temporal gyrus; L=left; LG=lingual gyrus; PCL=paracentral lobule; R=right; SFG=superior frontal gyrus.
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Table 4.
Between-group comparison of cortical activation maps (p<0.05, cluster corrected for multiple comparisons).
Comparison  Regions Side BA MNI coordinates (x,y,z) Cluster Size Max z
AAs > CTRLs IPL L 40 −64, −34, 34 525 3.56
Insula R 13 42, −2, −8 516 3.13
CAs > CTRLs SFG L 6 −24, −2, 68 1515 3.27
PC L 7 −22, −64, 54 722 3.41
AAs < CAs MedFG L 9 −8, 52, 34 799 −4.22
Anatomical coordinates in the standard MNI space, maximum z-values and cluster size for clusters showing significantly different activation in 
patient subgroups vs CTRLs and in AAs vs CAs (two-sample t-test, FEW-corrected for multiple comparisons at cluster level, p<0.05). 
Abbreviations: AAs=African-Americans, BA=Brodmann area, CAs=Caucasians, CTRLs=controls, IPL=inferior parietal lobule, L=left, 
MedFG=medial frontal gyrus, PC=precuneus, , R=right, SFG=superior frontal gyrus.
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